Home/ Supplements/ Vitamin K/ Full Spectrum Vitamin K2

Full Spectrum Vitamin K2

product on market Softgel Capsule InnovixLabs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is supported by moderate to strong evidence for promoting bone health and cardiovascular function by regulating calcium deposition. Research indicates it works synergistically with Vitamin D to improve bone mineral density. The evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Full Spectrum Vitamin K2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mcg (417% DV)
4.2× RDA — above typical dose 275 studies (A:9, B:175)
100 mcg (83% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Medium Chain Triglyceride Oil Gelatin Glycerin Water, Purified Carob
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: For general health, take one softgel per day. For heart and arterial health, take two softgels per day. Best if consumed with a meal.

Warnings & Precautions

If you are pregnant, nursing, or taking any prescription medication (especially anticoagulants like Warfarin/Coumadin), talk to your doctor before use.

Keep out of reach of children.

May contain ingredients sourced from nightshade.

Formulation Notes

Vitamin K2 exists in several forms, two major ones being MK-4 and MK-7. MK-4 is present in the brain, and preliminary research suggests K2 is important for bone health, brain health, and cardiovascular health.

Does not contain: dairy, eggs, corn, fish, shellfish, peanuts, wheat/gluten, soy, sugar, yeast, artificial colors or flavors. All ingredients are non-BE (Bioengineered). Soy free.

MK-4 + MK-7 500 mcg MK-4 100 mcg MK-7

Healthy bones and arteries

Source: Encapsulated, packaged, and third-party tested in USA with domestic and international ingredients.

Additional Information

Store at room temperature.

Metadata

Product Details

UPC / SKU7 94504 98465 1
DSLD Entry Date2025-07-24
Product TypeVitamin
FormSoftgel Capsule
BrandInnovixLabs
DSLD ID334984
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K-2
GNC Preventive Nutrition · Softgel Capsule
100
Vitamin K-2
NewtonEverett · Softgel Capsule
100
Low-Dose Vitamin K2 45 mcg
Life Extension · Softgel Capsule
100
Natural Vitamin K-2 Bioactive Form
Vitamin World · Softgel Capsule
100
Vitamin K2 50 mcg
Vitacost · Softgel Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from InnovixLabs View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.